345 related articles for article (PubMed ID: 15370109)
1. Histopathological characteristics of malignant melanoma affecting mucous membranes: a unifying concept of histogenesis.
Saida T; Kawachi S; Takata M; Kurita H; Kurashina K; Kageshita T; Tonogi M; Okazaki Y; Yamane GY; Takubo K; Ueyama Y
Pathology; 2004 Oct; 36(5):404-13. PubMed ID: 15370109
[TBL] [Abstract][Full Text] [Related]
2. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
3. Significance of dermoscopic patterns in detecting malignant melanoma on acral volar skin: results of a multicenter study in Japan.
Saida T; Miyazaki A; Oguchi S; Ishihara Y; Yamazaki Y; Murase S; Yoshikawa S; Tsuchida T; Kawabata Y; Tamaki K
Arch Dermatol; 2004 Oct; 140(10):1233-8. PubMed ID: 15492186
[TBL] [Abstract][Full Text] [Related]
4. MSG-1 expression in benign and malignant melanocytic lesions of cutaneous and mucosal epithelium.
Sedghizadeh PP; Williams JD; Allen CM; Prasad ML
Med Sci Monit; 2005 Jul; 11(7):BR189-94. PubMed ID: 15990678
[TBL] [Abstract][Full Text] [Related]
5. Ideas in pathology. Malignant melanoma in situ: the evolution of a concept.
Dubow BE; Ackerman AB
Mod Pathol; 1990 Nov; 3(6):734-44. PubMed ID: 2263599
[TBL] [Abstract][Full Text] [Related]
6. Early acral melanoma in situ: correlation between the parallel ridge pattern on dermoscopy and microscopic features.
Ishihara Y; Saida T; Miyazaki A; Koga H; Taniguchi A; Tsuchida T; Toyama M; Ohara K
Am J Dermatopathol; 2006 Feb; 28(1):21-7. PubMed ID: 16456320
[TBL] [Abstract][Full Text] [Related]
7. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
Fröhlich E; Mack AF; Garbe C; Klessen C
Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
[TBL] [Abstract][Full Text] [Related]
8. The histopathology of cutaneous malignant melanoma.
Barnhill RL; Mihm MC
Semin Diagn Pathol; 1993 Feb; 10(1):47-75. PubMed ID: 8506417
[TBL] [Abstract][Full Text] [Related]
9. Borderline and atypical melanocytic lesions.
Brodell RT; Santa Cruz DJ
Semin Diagn Pathol; 1985 Feb; 2(1):63-86. PubMed ID: 3916688
[TBL] [Abstract][Full Text] [Related]
10. Combined naevus: a benign lesion frequently misdiagnosed both clinically and pathologically as melanoma.
Scolyer RA; Zhuang L; Palmer AA; Thompson JF; McCarthy SW
Pathology; 2004 Oct; 36(5):419-27. PubMed ID: 15370111
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic beta-catenin is lacking in a subset of melanoma-associated naevi, but is detectable in naevus-associated melanomas: potential implications for melanoma tumorigenesis?
De Panfilis G; Ferrari D; Santoro S; Ricci R; Lombardi M; Pedrazzi G; Pepe C; Cortelazzi C; Santini M
Br J Dermatol; 2009 Mar; 160(3):600-8. PubMed ID: 19183173
[TBL] [Abstract][Full Text] [Related]
12. Simulators of malignant melanoma of the skin.
Cerroni L; Kerl H
Eur J Dermatol; 1998 Sep; 8(6):388-96. PubMed ID: 9729049
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of tumour-infiltrating CD4+CD25+FOXP3+ regulatory T cells in human cutaneous benign and atypical naevi, melanomas and melanoma metastases.
Mourmouras V; Fimiani M; Rubegni P; Epistolato MC; Malagnino V; Cardone C; Cosci E; Nisi MC; Miracco C
Br J Dermatol; 2007 Sep; 157(3):531-9. PubMed ID: 17596146
[TBL] [Abstract][Full Text] [Related]
14. Dermoscopy of pigmented lesions on mucocutaneous junction and mucous membrane.
Lin J; Koga H; Takata M; Saida T
Br J Dermatol; 2009 Dec; 161(6):1255-61. PubMed ID: 19673880
[TBL] [Abstract][Full Text] [Related]
15. The effect of the sun on expression of beta-catenin, p16 and cyclin d1 proteins in melanocytic lesions.
Demirkan NC; Kesen Z; Akdag B; Larue L; Delmas V
Clin Exp Dermatol; 2007 Nov; 32(6):733-9. PubMed ID: 17868395
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of patients at high risk for cutaneous malignant melanoma using digital dermoscopy.
Bauer J; Blum A; Strohhäcker U; Garbe C
Br J Dermatol; 2005 Jan; 152(1):87-92. PubMed ID: 15656806
[TBL] [Abstract][Full Text] [Related]
17. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
18. A retrospective study addressed to understanding what predicts severe histological dysplasia/early melanoma in excised atypical melanocytic lesions.
Strauss RM; Elliott F; Affleck P; Boon AP; Newton-Bishop JA
Br J Dermatol; 2007 Oct; 157(4):758-64. PubMed ID: 17714559
[TBL] [Abstract][Full Text] [Related]
19. Clinical selection of melanocytic lesions for dermoscopy decreases the identification of suspicious lesions in comparison with dermoscopy without clinical preselection.
Seidenari S; Longo C; Giusti F; Pellacani G
Br J Dermatol; 2006 May; 154(5):873-9. PubMed ID: 16634889
[TBL] [Abstract][Full Text] [Related]
20. Specific dermoscopy patterns and amplifications of the cyclin D1 gene to define histopathologically unrecognizable early lesions of acral melanoma in situ.
Yamaura M; Takata M; Miyazaki A; Saida T
Arch Dermatol; 2005 Nov; 141(11):1413-8. PubMed ID: 16301388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
